TRIMEDX is leading the industry with our proven clinical engineering expertise, coupled with over 25 years of medical device data and our state-of-the-art technology ecosystem, to transform clinical assets into a strategic lever for your health system. Through our core offering we uncover previously hidden insights to: • support clinical asset planning • maximize ROI • ensure equipment availability, compliance, and safety • ensure the safety and security of your connected medical devices Our dedicated, centralized support models deliver world-class quality, regulatory, supply chain and IT services that focus solely on the delivery of clinical engineering and clinical asset management services. Our multitude of data sources are aggregated into the TRIMEDX Clinical Asset Informatics platform that delivers actionable insights at your fingertips. The TRIMEDX proven methodology consistently delivers immediate savings of 10-20% and persistent savings of an average of 10% less than market price through long-term optimization of clinical asset inventories.

As the largest independent, technology-enabled clinical asset management company in the United States, TRIMEDX provides strategic planning and management of clinical assets to drive operational cost savings, free up capital for new strategic initiatives and deliver improved risk management and cyber protection.

Lynx MD is a secure data network and medical intelligence platform that gives the healthcare ecosystem the ability to quickly and safely access real-world health and patient data to accelerate diagnostic and therapeutic solutions and improve patient outcomes.

Lynx.MD is a SaaS data-sharing platform. We do not compete with EHRs. The Lynx.MD platform bring together data from a variety of clinical sources including structured EMR data and unstructured data such as Clinical Notes, Scanned Reports, Waveforms, Pathology Reports, Imaging, PACs and DICOMs. By combining structured and unstructured data the platform provides a more compete view of the patient care journey.